Your browser doesn't support javascript.
loading
In vitro and in vivo characterization of a recombinant rhesus cytomegalovirus containing a complete genome.
Taher, Husam; Mahyari, Eisa; Kreklywich, Craig; Uebelhoer, Luke S; McArdle, Matthew R; Moström, Matilda J; Bhusari, Amruta; Nekorchuk, Michael; E, Xiaofei; Whitmer, Travis; Scheef, Elizabeth A; Sprehe, Lesli M; Roberts, Dawn L; Hughes, Colette M; Jackson, Kerianne A; Selseth, Andrea N; Ventura, Abigail B; Cleveland-Rubeor, Hillary C; Yue, Yujuan; Schmidt, Kimberli A; Shao, Jason; Edlefsen, Paul T; Smedley, Jeremy; Kowalik, Timothy F; Stanton, Richard J; Axthelm, Michael K; Estes, Jacob D; Hansen, Scott G; Kaur, Amitinder; Barry, Peter A; Bimber, Benjamin N; Picker, Louis J; Streblow, Daniel N; Früh, Klaus; Malouli, Daniel.
Affiliation
  • Taher H; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Mahyari E; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Kreklywich C; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Uebelhoer LS; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • McArdle MR; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Moström MJ; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Bhusari A; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
  • Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • E X; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Whitmer T; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Scheef EA; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Sprehe LM; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Roberts DL; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
  • Hughes CM; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
  • Jackson KA; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Selseth AN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Ventura AB; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Cleveland-Rubeor HC; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Yue Y; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Schmidt KA; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Shao J; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
  • Edlefsen PT; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
  • Smedley J; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Kowalik TF; Statistical Center for HIV/AIDS Research and Prevention, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
  • Stanton RJ; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Axthelm MK; Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  • Estes JD; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.
  • Hansen SG; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Kaur A; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Barry PA; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Bimber BN; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Picker LJ; Tulane National Primate Research Center, Tulane University, Covington, Louisiana, United States of America.
  • Streblow DN; Center for Comparative Medicine and Department of Medical Pathology, University of California, Davis, California, United States of America.
  • Früh K; Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
  • Malouli D; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, Oregon, United States of America.
PLoS Pathog ; 16(11): e1008666, 2020 11.
Article in En | MEDLINE | ID: mdl-33232376
ABSTRACT
Cytomegaloviruses (CMVs) are highly adapted to their host species resulting in strict species specificity. Hence, in vivo examination of all aspects of CMV biology employs animal models using host-specific CMVs. Infection of rhesus macaques (RM) with rhesus CMV (RhCMV) has been established as a representative model for infection of humans with HCMV due to the close evolutionary relationships of both host and virus. However, the only available RhCMV clone that permits genetic modifications is based on the 68-1 strain which has been passaged in fibroblasts for decades resulting in multiple genomic changes due to tissue culture adaptations. As a result, 68-1 displays reduced viremia in RhCMV-naïve animals and limited shedding compared to non-clonal, low passage isolates. To overcome this limitation, we used sequence information from primary RhCMV isolates to construct a full-length (FL) RhCMV by repairing all mutations affecting open reading frames (ORFs) in the 68-1 bacterial artificial chromosome (BAC). Inoculation of adult, immunocompetent, RhCMV-naïve RM with the reconstituted virus resulted in significant viremia in the blood similar to primary isolates of RhCMV and furthermore led to high viral genome copy numbers in many tissues at day 14 post infection. In contrast, viral dissemination was greatly reduced upon deletion of genes also lacking in 68-1. Transcriptome analysis of infected tissues further revealed that chemokine-like genes deleted in 68-1 are among the most highly expressed viral transcripts both in vitro and in vivo consistent with an important immunomodulatory function of the respective proteins. We conclude that FL-RhCMV displays in vitro and in vivo characteristics of a wildtype virus while being amenable to genetic modifications through BAC recombineering techniques.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viremia / Genome, Viral / Cytomegalovirus Infections / Cytomegalovirus Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: PLoS Pathog Year: 2020 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viremia / Genome, Viral / Cytomegalovirus Infections / Cytomegalovirus Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: PLoS Pathog Year: 2020 Document type: Article Affiliation country: